scispace - formally typeset
X

Xiang Luo

Researcher at University of Texas Southwestern Medical Center

Publications -  59
Citations -  6506

Xiang Luo is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: G protein-coupled receptor & Receptor. The author has an hindex of 33, co-authored 55 publications receiving 5532 citations. Previous affiliations of Xiang Luo include Huazhong University of Science and Technology.

Papers
More filters
Journal ArticleDOI

Heart repair by reprogramming non-myocytes with cardiac transcription factors

TL;DR: It is shown that four transcription factors, GATA4, HAND2, MEF2C and TBX5, can cooperatively reprogram adult mouse tail-tip and cardiac fibroblasts into beating cardiac-like myocytes in vitro and suggest a strategy for cardiac repair through reprogramming fibro Blasts resident in the heart with cardiogenic transcription factors or other molecules.
Journal ArticleDOI

Reprogramming of human fibroblasts toward a cardiac fate

TL;DR: Findings indicate that human fibroblasts can be reprogrammed to cardiac-like myocytes by forced expression of cardiac transcription factors with muscle-specific microRNAs and represent a step toward possible therapeutic application of this reprogramming approach.
Journal ArticleDOI

Gating of CFTR by the STAS domain of SLC26 transporters.

TL;DR: A reciprocal regulatory interaction between the S LC26T DRA, SLC26A6 and CFTR markedly activates CFTR by increasing its overall open probablity (NPo) sixfold and provides a new understanding of epithelial chloride and bicarbonate transport.
Journal ArticleDOI

Nitrosative stress drives heart failure with preserved ejection fraction

TL;DR: It is reported that concomitant metabolic and hypertensive stress in mice—elicited by a combination of high-fat diet and inhibition of constitutive nitric oxide synthase using Nω-nitro-l-arginine methyl ester—recapitulates the numerous systemic and cardiovascular features of HFpEF in humans.
Journal ArticleDOI

MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca²⁺ overload and cell death.

TL;DR: A pivotal role is revealed for miR-214 as a regulator of cardiomyocyte Ca²⁺ homeostasis and survival during cardiac injury, as well as repression of several downstream effectors of Ca�⁺ signaling that mediate cell death.